CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-17 | HANDLEY DANIEL E Director | Grant or award | +4,070 | 4,070 | ||
| 2020-06-17 | Schwartz Carl I. Chief Executive Officer | Grant or award | +4,070 | 1,611,981 | ||
| 2020-04-21 | Schwartz Carl I. Chief Executive Officer | Grant or award | +1,533,481 | $1.43 | $2.2M | 1,607,911 |
| 2020-04-04 | Vardzel Gerald J Jr Director | Conversion · Series D Convertible Preferred Stock | −62,843 | 0 | ||
| 2020-04-03 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +15,267 | 15,267 | ||
| 2020-03-31 | Vardzel Gerald J Jr Director | Grant or award · Stock Options (right to buy) | +3,174 | 3,174 | ||
| 2020-03-31 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +3,174 | 3,174 | ||
| 2020-03-31 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +3,174 | 3,174 | ||
| 2020-03-31 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +3,174 | 3,174 | ||
| 2020-03-31 | HANDLEY DANIEL E Director | Grant or award · Stock Options (right to buy) | +3,174 | 3,174 | ||
| 2020-03-31 | PRIOR PAMELA S Director | Grant or award · Stock Options (right to buy) | +3,174 | 3,174 | ||
| 2020-03-31 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +3,174 | 3,174 | ||
| 2020-01-31 | Schwartz Carl I. Chief Executive Officer | Other acquisition | +50,000 | 74,430 | ||
| 2020-01-31 | Schwartz Carl I. Chief Executive Officer | Other disposition · Third Amended and Restated Common Stock Purchase Warrant | −119,442 | 0 | ||
| 2019-12-31 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +5,747 | 5,747 | ||
| 2019-12-31 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +13,410 | 13,410 | ||
| 2019-12-31 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +5,747 | 5,747 | ||
| 2019-12-31 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +13,410 | 13,410 | ||
| 2019-10-01 | Schwartz Carl I. Chief Executive Officer | Other acquisition · Third Amended and Restated Common Stock Purchase Warrant | +11,506 | 1,205,923 | ||
| 2019-09-30 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +990 | 990 |
Page 12 of 20 · 384 trades